Diacomit (Chiesi) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: stiripentol
Brand name
(ARTG)
: DIACOMIT stiripentol 250 mg powder for oral suspension sachetDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
DIACOMIT is indicated for adjunctive treatment of generalised tonic-clonic and clonic seizures associated with severe myoclonic epilepsy in infancy (SMEI, also known as Dravet syndrome) in patients whose seizures are not adequately controlled with a benzodiazepine (usually clobazam) and valproate.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Powder, oral
- Oral
- Pale pink powder packaged in paper/Al/PE film composite
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Light
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 60 sachets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient stiripentol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
